| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OXSM | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | NSA2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | DCTD | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | ZNF579 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | SLC16A7 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | NOTCH2NL | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | ITFG1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | UPF2 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | WNT2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | OR13G1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
